Contact
searchSearch
HMP Global

November 2012 - FRMC

Challenges Associated with Schizophrenia
11/20/2013
Tim Casey
Schizophrenia is a disease caused by genetics, brain chemistry, or environmental factors that typically occurs in those between 16 and 35 years of age.
Schizophrenia is a disease caused by genetics, brain chemistry, or environmental factors that typically occurs in those between 16 and 35 years of age.
Schizophrenia is a disease...
11/20/2013
First Report Managed Care
Vascepa™, an Omega-3 Fatty Acid, for Patients with Severe Hypertriglyceridemia
11/27/2012
Tim Casey
Cincinnati—Approximately 4 million people in the United States have severe hypertriglyceridemia, which has been associated with heart disease, stroke, and other conditions. The effects are intensified in people with low high-density...
Cincinnati—Approximately 4 million people in the United States have severe hypertriglyceridemia, which has been associated with heart disease, stroke, and other conditions. The effects are intensified in people with low high-density...
Cincinnati—Approximately 4...
11/27/2012
First Report Managed Care
Lurasidone and Olanzapine in Patients with Schizophrenia
11/27/2012
Jill Sederstorm
Cincinnati—An indirect treatment comparison of 6 atypical antipsychotic (AAP) medications for schizophrenia found that patient discontinuation rates were lowest for lurasidone and olanzapine. The findings from the comparison were presented...
Cincinnati—An indirect treatment comparison of 6 atypical antipsychotic (AAP) medications for schizophrenia found that patient discontinuation rates were lowest for lurasidone and olanzapine. The findings from the comparison were presented...
Cincinnati—An indirect treatment...
11/27/2012
First Report Managed Care
Costs and Outcomes Comparison of Treatments for Hypertension
11/27/2012
Tori Socha
Cincinnati—Hypertension affects 1 in every 3 adults in the United States and prolonged hypertension can lead to severe complications, including stroke, congestive heart failure, renal failure, myocardial infarction, and other conditions that...
Cincinnati—Hypertension affects 1 in every 3 adults in the United States and prolonged hypertension can lead to severe complications, including stroke, congestive heart failure, renal failure, myocardial infarction, and other conditions that...
Cincinnati—Hypertension affects...
11/27/2012
First Report Managed Care
Comparison of Treatment Therapies for Hypertensive Patients
11/27/2012
Danielle Seltzer
Cincinnati—Hypertension affects >76 million adults in the United States, making it one of the most common chronic diseases. Over the long term, uncontrolled hypertension is associated with risk for cardiovascular diseases and complications...
Cincinnati—Hypertension affects >76 million adults in the United States, making it one of the most common chronic diseases. Over the long term, uncontrolled hypertension is associated with risk for cardiovascular diseases and complications...
Cincinnati—Hypertension affects...
11/27/2012
First Report Managed Care
Drug Burden Score Model in the Patient-Centered Medical Home
11/27/2012
Tori Socha
Cincinnati—Medication therapy management (MTM) often utilizes a combination of prescription drug data and patient demographic information to predict the risk of medication-related complications. At a Pharmacy Partnership Briefing session at...
Cincinnati—Medication therapy management (MTM) often utilizes a combination of prescription drug data and patient demographic information to predict the risk of medication-related complications. At a Pharmacy Partnership Briefing session at...
Cincinnati—Medication therapy...
11/27/2012
First Report Managed Care
Underutilization of Warfarin and Associated Costs
11/27/2012
Tori Socha
Cincinnati—Atrial fibrillation (AF), affecting approximately 2.3 million people in the United States, imposes a substantial clinical and economic burden and is associated with at least a 2-fold increase in the risk of stroke and...
Cincinnati—Atrial fibrillation (AF), affecting approximately 2.3 million people in the United States, imposes a substantial clinical and economic burden and is associated with at least a 2-fold increase in the risk of stroke and...
Cincinnati—Atrial fibrillation...
11/27/2012
First Report Managed Care
Exacerbation Rates and Costs of COPD in a Managed Care Population
11/27/2012
Tori Socha
Cincinnati—Chronic obstructive pulmonary disease (COPD), a progressive disease characterized by persistent airflow limitation, chronic and progressive dyspnea, cough, and sputum production, is often complicated by exacerbations. The...
Cincinnati—Chronic obstructive pulmonary disease (COPD), a progressive disease characterized by persistent airflow limitation, chronic and progressive dyspnea, cough, and sputum production, is often complicated by exacerbations. The...
Cincinnati—Chronic obstructive...
11/27/2012
First Report Managed Care

Department

Conference Insider
Association of ACS with Mortality and Morbidity
11/27/2012
Tori Socha
Cincinnati—Acute coronary syndrome (ACS) is one of the most commonly diagnosed cardiovascular illnesses in the United States and one that is responsible for significant morbidity and mortality. Nearly 1.2 million hospital discharges were...
Cincinnati—Acute coronary syndrome (ACS) is one of the most commonly diagnosed cardiovascular illnesses in the United States and one that is responsible for significant morbidity and mortality. Nearly 1.2 million hospital discharges were...
Cincinnati—Acute coronary...
11/27/2012
First Report Managed Care

News

News
Multiple Sclerosis Patients with High Relapse Rate
11/27/2012
Danielle Seltzer
Cincinnati—Relapsing-remitting multiple sclerosis (MS) is characterized by relapses of symptoms interspersed between periods of remission. Relapses can last for days, weeks, or months and are associated with significant disability and...
Cincinnati—Relapsing-remitting multiple sclerosis (MS) is characterized by relapses of symptoms interspersed between periods of remission. Relapses can last for days, weeks, or months and are associated with significant disability and...
Cincinnati—Relapsing-remitting...
11/27/2012
First Report Managed Care

Behind the Bill

Behind the Bill
SCOTUS Takes on the Nondelegation Doctrine: Surprising Reactions and What They Mean for Agency Power
04/02/2025
Katie Hayes, MJ
The Supreme Court recently heard arguments in Federal Communication Commission (FCC) v Consumers’ Research, a case that I covered in February and one that could dramatically reshape federal agency authority through the nondelegation...
The Supreme Court recently heard arguments in Federal Communication Commission (FCC) v Consumers’ Research, a case that I covered in February and one that could dramatically reshape federal agency authority through the nondelegation...
The Supreme Court recently heard...
04/02/2025
First Report Managed Care
Behind the Bill
Dr Oz’s Prescription for Making Medicaid “Viable at Every Level”
03/26/2025
Katie Hayes, MJ
On Tuesday, March 25, 2025, the Senate Finance Committee voted to advance Dr Mehmet Oz in his confirmation as the next head of the Centers for Medicare and Medicaid Services (CMS).1 The full Senate vote is expected “soon” (whatever that...
On Tuesday, March 25, 2025, the Senate Finance Committee voted to advance Dr Mehmet Oz in his confirmation as the next head of the Centers for Medicare and Medicaid Services (CMS).1 The full Senate vote is expected “soon” (whatever that...
On Tuesday, March 25, 2025, the...
03/26/2025
First Report Managed Care
Behind the Bill
The $880 Billion Question Continues: Dr Oz's Confirmation and the Future of Medicaid
03/19/2025
Katie Hayes, MJ
Last week, I explored the $880 billion question facing Congress—whether lawmakers could achieve their budget goals without cutting Medicaid. This week, that question took center stage as Dr Mehmet Oz, President Trump's nominee to lead the...
Last week, I explored the $880 billion question facing Congress—whether lawmakers could achieve their budget goals without cutting Medicaid. This week, that question took center stage as Dr Mehmet Oz, President Trump's nominee to lead the...
Last week, I explored the $880...
03/19/2025
First Report Managed Care
Behind the Bill
The $880 Billion Question: Can Congress Cut Spending Without Touching Medicaid?
03/12/2025
Katie Hayes, MJ
I’d like to step away from administrative law for a moment to provide a quick update on Medicaid. With news coming from all sides, what does the future of Medicaid actually look like? The House of Representatives narrowly passed a budget...
I’d like to step away from administrative law for a moment to provide a quick update on Medicaid. With news coming from all sides, what does the future of Medicaid actually look like? The House of Representatives narrowly passed a budget...
I’d like to step away from...
03/12/2025
First Report Managed Care
Behind the Bill
RFK Jr’s Public Comment Ban: The Silent Shift in Health Care Rulemaking
03/05/2025
Katie Hayes, MJ
The erosion of administrative law continues, and with it, the dismantling of decades-long precedent. In June, the Supreme Court overturned a 40-year-old doctrine that allowed federal agencies to interpret their own ambiguous statutes. Later...
The erosion of administrative law continues, and with it, the dismantling of decades-long precedent. In June, the Supreme Court overturned a 40-year-old doctrine that allowed federal agencies to interpret their own ambiguous statutes. Later...
The erosion of administrative...
03/05/2025
First Report Managed Care
Behind the Bill
Prevention Over Pills? The First 2 Weeks of Health Care’s New Direction
02/26/2025
Katie Hayes, MJ
The dust has barely settled from Robert F Kennedy Jr’s confirmation as Secretary of Health and Human Services (HHS), but the changes are already coming fast and furious—a key theme of the Trump Administration’s actions within the last several...
The dust has barely settled from Robert F Kennedy Jr’s confirmation as Secretary of Health and Human Services (HHS), but the changes are already coming fast and furious—a key theme of the Trump Administration’s actions within the last several...
The dust has barely settled from...
02/26/2025
First Report Managed Care
Behind the Bill
The Nondelegation Doctrine: The Next Constitutional Showdown (Part 2)
02/19/2025
Katie Hayes, MJ
Last week, I explored the potential revival of the nondelegation doctrine through Federal Communication Commission v Consumers’ Research. Today, I want to examine what this could mean for health care regulation by considering the parallels...
Last week, I explored the potential revival of the nondelegation doctrine through Federal Communication Commission v Consumers’ Research. Today, I want to examine what this could mean for health care regulation by considering the parallels...
Last week, I explored the...
02/19/2025
First Report Managed Care
Behind the Bill
The Nondelegation Doctrine: The Next Constitutional Showdown (Part 1)
02/12/2025
Katie Hayes, MJ
Just when you thought the dust had settled from the Chevron decision, the Supreme Court is gearing up to hear arguments in Federal Communications Commission v Consumers' Research next month, potentially reviving the long-dormant nondelegation...
Just when you thought the dust had settled from the Chevron decision, the Supreme Court is gearing up to hear arguments in Federal Communications Commission v Consumers' Research next month, potentially reviving the long-dormant nondelegation...
Just when you thought the dust...
02/12/2025
First Report Managed Care
Behind the Bill
No, President Trump Did Not Actually Sign an Executive Order That Would Increase Drug Costs for Beneficiaries
02/05/2025
Katie Hayes, MJ
On inauguration day, President Trump issued an executive order rescinding several Biden-era health care initiatives, including 3 experimental drug pricing models developed by the Center for Medicare and Medicaid Innovation (CMMI). Oh boy did...
On inauguration day, President Trump issued an executive order rescinding several Biden-era health care initiatives, including 3 experimental drug pricing models developed by the Center for Medicare and Medicaid Innovation (CMMI). Oh boy did...
On inauguration day, President...
02/05/2025
First Report Managed Care
Behind the Bill
Robert F. Kennedy Jr’s Confirmation and the Unexpected Turn in the Drug Pricing Debate
01/29/2025
Katie Hayes, MJ
The Plot Thickens in Drug Pricing Drama Just when you thought the drug pricing debate couldn't get more interesting, Robert F. Kennedy Jr adds an unexpected twist. During closed-door Senate meetings, President Trump’s US Department of...
The Plot Thickens in Drug Pricing Drama Just when you thought the drug pricing debate couldn't get more interesting, Robert F. Kennedy Jr adds an unexpected twist. During closed-door Senate meetings, President Trump’s US Department of...
The Plot Thickens in Drug...
01/29/2025
First Report Managed Care

Subscribe and Stay Ahead With Daily Industry Insights

First Report Managed Care Newsletter

Trending Articles

News
Long-Wave Infrared Thermography Helps LTACH Achieve Pressure Injury Success
04/25/2023
Jolynn Tumolo
“The LTACH facility maintained a zero hospital-acquired pressure injury rate for 10 months after implementation of long-wave infrared thermography," researchers reported.
“The LTACH facility maintained a zero hospital-acquired pressure injury rate for 10 months after implementation of long-wave infrared thermography," researchers reported.
“The LTACH facility maintained a...
04/25/2023
First Report Managed Care
Headshot of Barbara Konkle, MD, on a blue background underneath the PopHealth Perspectives logo.
Podcasts
Discussing a Novel Factor VIII Replacement Therapy for Patients With Hemophilia
05/24/2023
Maria Asimopoulos
Barbara Konkle, MD, professor of medicine, Division of Hematology, University of Washington; research director, Washington Center for Bleeding Disorders; and director, Hemostasis, Platelet Immunology and Genomics Laboratory at Bloodworks...
Barbara Konkle, MD, professor of medicine, Division of Hematology, University of Washington; research director, Washington Center for Bleeding Disorders; and director, Hemostasis, Platelet Immunology and Genomics Laboratory at Bloodworks...
Barbara Konkle, MD, professor of...
05/24/2023
First Report Managed Care
Formulary Frontlines®
Challenges, Treatment Options, and Costs Linked With Upper Tract Urothelial Carcinoma
06/20/2023
Julie Gould
Bladder cancer was the sixth most common cancer type in the United States in 2020, behind breast, lung, prostate, colon, and skin cancers.
Bladder cancer was the sixth most common cancer type in the United States in 2020, behind breast, lung, prostate, colon, and skin cancers.
Bladder cancer was the sixth...
06/20/2023
First Report Managed Care
News
Medicare Could Save $1 Billion by Considering Added Benefit of Expensive Part B Drugs
07/18/2023
Jolynn Tumolo
Researchers find that Medicare could potentially save $1 billion by considering the added therapeutic benefit of expensive Part B drugs and implementing reference pricing.
Researchers find that Medicare could potentially save $1 billion by considering the added therapeutic benefit of expensive Part B drugs and implementing reference pricing.
Researchers find that Medicare...
07/18/2023
First Report Managed Care
News
New Platform Leverages Real-World Evidence for Type 2 Inflammation Immunological Disease Research
08/07/2023
Hannah Musick
Researchers introduce Immunolab, a platform that generates real-world evidence to provide insights and conduct research on immunological diseases related to type 2 inflammation.
Researchers introduce Immunolab, a platform that generates real-world evidence to provide insights and conduct research on immunological diseases related to type 2 inflammation.
Researchers introduce Immunolab,...
08/07/2023
First Report Managed Care

November 2012 Volume 9 Issue 11

View Issue Archive
Editorial Correspondence

Specialties

Events

Year Round Education

HMP Global Products

HMP Education Logo
HMP Omnimedia Logo
HMP Europe Logo
© 2025 HMP Global. All Rights Reserved.
Cookie Policy Privacy Policy Term of Use